Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Theravance Biopharma, Inc. |
| DTOISS |
| 223,917 |
| — |
| — |
| -63.0% |
| Open the original filing on SEC.gov |
| Aug 20 | TBPH | Theravance Biopharma, Inc. | FTAX | 7,952 | $16.95 | $134.8K | -2.2% | Open the original filing on SEC.gov |
| May 20 | TBPH | Theravance Biopharma, Inc. | FTAX | 8,829 | $16.55 | $146.1K | -2.4% | Open the original filing on SEC.gov |
| Apr 1 | TBPH | Theravance Biopharma, Inc. | AGRANT | 37,500 | — | — | +11.2% | Open the original filing on SEC.gov |
| Feb 20 | TBPH | Theravance Biopharma, Inc. | FTAX | 20,833 | $19.66 | $409.6K | -5.9% | Open the original filing on SEC.gov |
| Nov 20, 2025 | TBPH | Theravance Biopharma, Inc. | FTAX | 19,024 | $17.90 | $340.5K | -5.1% | Open the original filing on SEC.gov |
| Aug 20, 2025 | TBPH | Theravance Biopharma, Inc. | FTAX | 9,762 | $13.39 | $130.7K | -2.5% | Open the original filing on SEC.gov |
| May 20, 2025 | TBPH | Theravance Biopharma, Inc. | FTAX | 9,743 | $9.45 | $92.1K | -2.5% | Open the original filing on SEC.gov |